DYNAVAX TECHNOLOGIES CORP Business Operations Contracts & Agreements

Amendment No. 3 to Supply Agreement, dated effective as of April 26, 2023, by and between Company and Biological E. Limited (Filed With SEC on August 3, 2023)

Amendment No. 1 to Supply Agreement, dated effective as of June 23, 2022, by and between the Company and Biological E. Limited (Filed With SEC on November 3, 2022)

Amendment No. 2 to Supply Agreement, dated effective as of September 30, 2022, by and between the Company and Biological E. Limited (Filed With SEC on November 3, 2022)

First Amendment to Commercial Manufacturing and Supply Agreement dated September 10, 2021 by and between Baxter Pharmaceutical Solutions LLC and Dynavax Technologies Corporation (Filed With SEC on November 4, 2021)

Supply Agreement dated June 29, 2021 by and among Company, Zhejiang Clover Biopharmaceuticals, Inc., and Clover Biopharmaceuticals (Hong Kong) Co., Limited (Filed With SEC on August 4, 2021)

Supply Agreement dated July 1, 2021 by and between Company and Biological E. Limited (Filed With SEC on August 4, 2021)

Supply Agreement, dated September 11, 2020, by and among the Company, Valneva Scotland Limited and Valneva Austria GmbH (Filed With SEC on November 5, 2020)

Sales Agreement, dated August 6, 2020, between the Company and Cowen and Company, LLC (Filed With SEC on August 6, 2020)

Form of Indemnification Agreement (Filed With SEC on November 7, 2019)

Master Services Agreement, dated January 11, 2016, between the Company and inVentiv Commercial Services, LLC (Filed With SEC on March 8, 2018)

Project Agreement, dated October 31, 2017 between the Company and inVentiv Commercial Services, LLC (Filed With SEC on March 8, 2018)

First Amendment to Project Agreement, dated October 31, 2017 between Company and inVentiv Commercial Services, LLC (Filed With SEC on March 8, 2018)

Commercial Manufacturing and Supply Agreement, dated November 22, 2013, between Company and Baxter Pharmaceutical Solutions LLC (Filed With SEC on March 8, 2018)

Supply Agreement, dated November 2, 2016, between Company and Becton, Dickinson and Company (Filed With SEC on March 8, 2018)

Supply Agreement, dated October 1, 2012, between Company and Nitto Denko Avecia, Inc (Filed With SEC on March 8, 2018)

Supply Agreement, dated July 27, 2016, between Company and West Pharmaceutical Services, Inc (Filed With SEC on March 8, 2018)

Sales Agreement, dated November 3, 2017, by and between the Company and Cowen and Company, LLC (Filed With SEC on November 3, 2017)

RESEARCH COLLABORATION AND LICENSE AGREEMENT by and between ASTRAZENECA AB and DYNAVAX TECHNOLOGIES CORPORATION DATE: 1 September 2006 (Filed With SEC on October 31, 2011)

BETWEEN GLAXO GROUP LIMITED AND DYNAVAX TECHNOLOGIES CORPORATION RESEARCH AND DEVELOPMENT COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on March 6, 2009)